A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
HealthDay on MSN5d
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVIDExtended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.
The findings run counter to a clinical trial which found no benefit from Paxlovid in long COVID patients WEDNESDAY, Jan. 8, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results